zoledronic acid has been researched along with Acute Kidney Injury in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Eastell, R; Khwaja, A; Peel, N; Salam, S; Schini, M; Thomas, E; Toronjo-Urquiza, L; Walsh, JS | 1 |
| Gupta, S; Mount, DB; Nigwekar, SU; Portales-Castillo, I; Rennke, HG; Yu, EW | 1 |
| Fixen, CW; Fixen, DR | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Cipriani, C; Clementelli, C; Colangelo, L; Fassino, V; Manai, R; Minisola, S; Nieddu, L; Pepe, J | 1 |
| Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A | 1 |
| Ashcroft, AJ; Bell, SE; Boyd, KD; Byrne, J; Child, JA; Cook, G; Davies, FE; Drayson, MT; Feyler, S; Gregory, WM; Jackson, GH; Morgan, GJ; Navarro Coy, N; Osborne, WL; Owen, RG; Roddie, H; Ross, FM; Rudin, C; Szubert, AJ; Wu, P | 1 |
| Joensuu, TK | 1 |
| Ando, R; Fukami, K; Hashiguchi, M; Hazama, T; Koike, K; Morishige, S; Nagano, M; Nishida, H; Okuda, S; Taguchi, K; Tamaki, K; Ueda, S; Yoshimura, J | 1 |
| Dowell, JE; Jean, GW; Keisner, SV; Shah, SR; Ussery, SM | 1 |
| Fukami, K; Koike, K; Morishige, S; Okamura, T; Okuda, S; Taguchi, K; Yakushiji, K | 1 |
| Hirschberg, R | 1 |
| Cull, G; Henley, D; Kaye, J; Walsh, J | 1 |
| Peña, JM; Pernaute, R; Vicente, C; Vives, P | 1 |
| Bodmer, M; Kummer, O; Ramazzina, C; Rätz Bravo, AE; Zysset Aschmann, Y | 1 |
2 review(s) available for zoledronic acid and Acute Kidney Injury
| Article | Year |
|---|---|
Renal complications from bisphosphonate treatment.
Topics: Acute Kidney Injury; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Kidney; Kidney Diseases; Nephrotic Syndrome; Pamidronate; Risk Factors; Zoledronic Acid | 2012 |
[Zoledronate-associated end stage renal failure and hypocalcaemia].
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Biopsy; Bone Density Conservation Agents; Calcium; Creatinine; Diphosphonates; Disease Progression; Female; Follow-Up Studies; Humans; Hypocalcemia; Imidazoles; Kidney Failure, Chronic; Kidney Tubules; Middle Aged; Multiple Myeloma; Pamidronate; Renal Dialysis; Risk Factors; Switzerland; Time Factors; Vitamin D; Zoledronic Acid | 2007 |
1 trial(s) available for zoledronic acid and Acute Kidney Injury
| Article | Year |
|---|---|
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Drug Administration Schedule; England; Female; Follow-Up Studies; Humans; Imidazoles; Incidence; Male; Middle Aged; Multiple Myeloma; Osteolysis; Zoledronic Acid | 2014 |
12 other study(ies) available for zoledronic acid and Acute Kidney Injury
| Article | Year |
|---|---|
Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
Topics: Acute Kidney Injury; Creatinine; Glomerular Filtration Rate; Humans; Osteoporosis; Zoledronic Acid | 2022 |
Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer.
Topics: Acute Kidney Injury; Amino Acids; Bicarbonates; Bone Density Conservation Agents; Fanconi Syndrome; Humans; Neoplasms; Zoledronic Acid | 2022 |
Renal safety of zoledronic acid for osteoporosis in adults 75 years and older.
Topics: Acute Kidney Injury; Aged; Creatinine; Cross-Sectional Studies; Glomerular Filtration Rate; Humans; Kidney; Osteoporosis; Retrospective Studies; Zoledronic Acid | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Bone Density Conservation Agents; Calcium; Chemokine CCL2; Diphosphonates; Female; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Imidazoles; Infusions, Intravenous; Interleukin-18; Male; Osteoporosis; Pilot Projects; Renal Elimination; Zoledronic Acid | 2017 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid | 2013 |
Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Creatinine; Diphosphonates; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Male; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Retreatment; Risk Assessment; Treatment Outcome; Zoledronic Acid | 2008 |
[Case of acute kidney injury related to intravenous zoledronic acid in a patient with multiple myeloma].
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Diseases; Dexamethasone; Diphosphonates; Doxorubicin; Humans; Imidazoles; Injections, Intravenous; Male; Multiple Myeloma; Renal Dialysis; Treatment Outcome; Vincristine; Zoledronic Acid | 2009 |
Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Time Factors; Zoledronic Acid | 2012 |
[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Injections, Intravenous; Male; Multiple Myeloma; Pyrazines; Zoledronic Acid | 2011 |
Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Topics: Acute Kidney Injury; Aged; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Diphosphonates; Fatal Outcome; Female; Humans; Hypocalcemia; Imidazoles; Injections, Intravenous; Magnesium Deficiency; Male; Middle Aged; Multiple Myeloma; Pamidronate; Zoledronic Acid | 2005 |
[Acute kidney failure caused by zoledronic acid (Zometa)].
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Diphosphonates; Female; Humans; Imidazoles; Zoledronic Acid | 2006 |